Reactive astrocytosis (also termed astrogliosis or astrocyte reactivity) is a hallmark of CNS injury and neurodegeneration, characterized by morphological and functional changes in astrocytes in response to pathological stimuli["@pekny2014"]. Once viewed as a passive response, reactive astrocytes are now recognized as active players in neurodegenerative processes, exhibiting both beneficial (protective) and detrimental (harmful) effects depending on the context and disease stage["@sofroniew2010"].
The reactive astrocyte phenotype encompasses a spectrum of changes including cellular hypertrophy, proliferation, upregulation of glial fibrillary acidic protein (GFAP), and altered gene expression profiles. These changes can influence disease progression through effects on neuroinflammation, blood-brain barrier integrity, synaptic function, and metabolic support["@ben2015"].
Molecular Mechanisms of Astrocyte Reactivity
Triggering Factors
Reactive astrocytosis is initiated by various signals:
Damage-associated molecular patterns (DAMPs):
ATP and adenosine released from damaged neurons
HMGB1 released from dying cells
Mitochondrial DAMPs
Heat shock proteins
...
Reactive Astrocytosis
Overview
Mermaid diagram (expand to render)
Reactive astrocytosis (also termed astrogliosis or astrocyte reactivity) is a hallmark of CNS injury and neurodegeneration, characterized by morphological and functional changes in astrocytes in response to pathological stimuli["@pekny2014"]. Once viewed as a passive response, reactive astrocytes are now recognized as active players in neurodegenerative processes, exhibiting both beneficial (protective) and detrimental (harmful) effects depending on the context and disease stage["@sofroniew2010"].
The reactive astrocyte phenotype encompasses a spectrum of changes including cellular hypertrophy, proliferation, upregulation of glial fibrillary acidic protein (GFAP), and altered gene expression profiles. These changes can influence disease progression through effects on neuroinflammation, blood-brain barrier integrity, synaptic function, and metabolic support["@ben2015"].
Molecular Mechanisms of Astrocyte Reactivity
Triggering Factors
Reactive astrocytosis is initiated by various signals:
Damage-associated molecular patterns (DAMPs):
ATP and adenosine released from damaged neurons
HMGB1 released from dying cells
Mitochondrial DAMPs
Heat shock proteins
Pro-inflammatory cytokines:
IL-1β and TNF-α from activated microglia
IFN-γ from infiltrating immune cells
IL-6 and IL-17
Pathogen-associated molecular patterns (PAMPs):
Viral/bacterial products
Amyloid-β aggregates
α-Synuclein aggregates
Signaling Pathways
Multiple pathways mediate astrocyte reactivity:
NF-κB pathway:
Central regulator of inflammatory gene expression
Activated by TNF-α, IL-1β, and DAMPs
Controls GFAP, cytokines, and chemokines
JAK/STAT pathway:
STAT3 phosphorylation in reactive astrocytes
Essential for astrocyte scar formation
Mediated by IL-6 family cytokines
MAPK pathways:
p38 MAPK involved in inflammatory response
ERK activation regulates proliferation
JNK contributes to oxidative stress
Morphological Changes
Reactive astrocytes exhibit:
Hypertrophy: Enlarged cell bodies and processes
Process extension: Increased elaboration of processes
Proliferation: Cell division in response to injury
GFAP upregulation: 5-10 fold increase in GFAP expression
Intermediate filament reorganization: Vimentin and nestin also upregulated
Heterogeneity of Reactive Astrocytes
A1 vs A2 Phenotypes
Based on transcriptomic analysis, two major reactive astrocyte phenotypes were identified[@liddelow2017]:
A1 (Neurotoxic) Reactive Astrocytes:
Induced by microglial IL-1α, TNF, and C1q
Upregulate complement components (C3)
Lose normal supportive functions
Become toxic to neurons and oligodendrocytes
Predominant in Alzheimer's, Parkinson's, ALS, multiple sclerosis
A2 (Neuroprotective) Reactive Astrocytes:
Induced by ischemic injury
Upregulate neurotrophic factors (GDNF, BDNF)
Enhance synaptic function
Promote tissue repair
Predominant in acute injury
Context-Dependent Functions
The functional outcome of astrocyte reactivity depends on:
Disease stage: Early reactivity may be protective; chronic reactivity is harmful
Astrocyte subset: Regional differences in astrocyte populations